6-K

AURINIA PHARMACEUTICALS INC. 6-K

Company: Aurinia Pharmaceuticals Inc.
Filed: November 14, 2019
Period of Report: November 14, 2019
Accession Number: 0001157523-19-002270

View Document ↗ View on SEC.gov ↗